At PCG Molecular, LLC, we are more than just a syndromic preventive care diagnostic company. We are a team of dedicated individuals driven by a passion to make a significant impact on national disease prevention and survival rates. Our company is committed to revolutionizing the healthcare industry by leading the way in research and development of genetic, molecular screens that detect problems early, are easy to administer, and bring pliable business models to practitioners that incentivize change.

 

As a proven pioneer in the industry, our innovative approach is guided by our desire to educate patients and practitioners on the importance of non-invasive, preventive screenings that play a vital role in ensuring longer lifespans. Our team of highly-trained, Board Certified pathologists and molecular biologists boast over twenty years of pathology experience, providing physicians, hospitals, and patients with unparalleled expertise and quality diagnostic services.

 

We believe that early detection is the key to preventing diseases from becoming major health issues. That's why our mission is to provide genetic molecular screenings that detect early DNA abnormalities before they become problematic. By placing an emphasis on preventive care, we aim to contribute to a healthier and happier society.

 

At PCG Molecular, we are committed to making a positive impact on the healthcare landscape, and we will continue to strive towards our goal of contributing to a world where disease prevention is prioritized, and every individual can lead a fulfilling, healthy life.